biocon

Biocon – Momentum Watch Important Levels:

Support: ₹415 – ₹405 Resistance: ₹445 – ₹460 Structure: Recovery with strong earnings support Business: Global biopharmaceutical company focused on biosimilars, generics and novel biologics. Strong exposure to global healthcare and affordable medicines. Earnings / Trigger: Biocon reported Q1 FY27 net profit of ₹141 crore, a massive increase from ₹31 crore a year earlier, while operating revenue increased 10% to ₹4,336 crore. Biopharma revenue grew 17%. Verdict: 👉 Strong pharma earnings momentum 👉 Watch the ₹445–₹460 zone for further strength